EyePoint Pharmaceuticals, Inc.

EYPT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.85-3.51%

2026-09-18

Financials

Valuation Metrics

EyePoint Pharmaceuticals, Inc.'s Market Cap is $332M. At end of 2025 it was $1.52B. Ranked #2911 of 3,121 in US market (top 93%), #1306 of 1,463 on NASDAQ (top 89%), #237 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 89%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$332M	US#2,911/3,121 Sec#237/266
Revenue	$3M	US#2,866/3,121 Sec#185/266
Net Income	$-307M	US—/3,121 Sec—/266
Total Assets	$228M	US#2,972/3,121 Sec#240/266
Net Assets	$166M	US#2,727/3,121 Sec#200/266
Value
P/B	1.99x	US#1,293/3,121 Sec#55/266
P/S	119.01x	US#2,953/3,121 Sec#181/266
FCF Yield	-81.73%	US—/3,121 Sec—/266
Profitability
ROE	-184.27%	US#2,841/3,121 Sec#216/266
Op. Margin	-11365.22%	US#2,872/3,121 Sec#187/266
Revenue Growth	-94.63%	US#2,772/3,121 Sec#185/266
Financial Health
Debt Ratio	37.12%	US#428/3,121 Sec#124/266
Total Debt	$22M	US#2,743/3,121 Sec#187/266
FCF	$-271M	US#2,833/3,121 Sec#228/266
Cash	$110M	US#2,172/3,121 Sec#167/266
Current Ratio	4.50x	US#531/3,121 Sec#159/266
Performance
1Y Return	-72.02%	US#3,075/3,121 Sec#261/266
1M Return	-38.89%	US#3,065/3,121 Sec#259/266
From 52W High	-79.85%	US#3,075/3,121 Sec#259/266
1Y MDD	-81.70%	US#3,076/3,121 Sec#258/266
Trading
Volume	6,476,079 shares	US#232/3,121 Sec#17/266
Trading Value	$25M	US#1,696/3,121 Sec#134/266
Per Share
EPS	$-3.56	US—/3,121 Sec—/266
BPS	$1.93	US#2,581/3,121 Sec#181/266